Yes, the screening is completely safe and painless. It is non-invasive, requires no blood tests, and feels similar to a standard blood pressure check.
‍
What sets this screening apart is what happens with the data. The CardiAction platform combines advanced telemetry from the BP+ machine with key biometric inputs such as age, sex, height, and other factors to generate a more comprehensive cardiovascular risk profile. This includes insights into central blood pressure, arterial stiffness, cardiac workload and vascular resistance.
‍
The process may feel simple, but the analysis behind it is far more sophisticated than a regular blood pressure test, helping you better understand your cardiovascular event risk.

You can get a Cardiovascular Disease (CVD) event risk screening (heart attack and stroke), from CardiAction Screening Australia, by booking an appointment with your nearest CardiAction Screening Pharmacy. This check is particularly recommended for eligible individuals, such as those 40 and over (or 30 and over for Aboriginal and Torres Strait Islander people). Your CardiAction Screener will use the CardiAction Pulse Wave Analysis device that is connected to the CardiAction Platform to assess your risk and can provide a plan for managing your heart health through lifestyle changes, supplements and other changes and may even refer you to your GP.

How to get a CVD risk screening:

1. Book a CardiAction heart & artery health check with your local pharmacy: Find your nearest locations at CardiAction Screening Australia Locations page.

2. Eligibility: This check is for eligible patients, typically those aged 40 and over, or 30 and over for Aboriginal and Torres Strait Islander individuals.

3. This 20 minute comprehensive screening could save your life

What happens during the check:

· Risk Assessment:
 Your screener will use tools like the Australian CardiAction Platform to assess your risk of a heart attack or stroke over the next five years.

· Health Plan:
 Based on your results, your CardiAction Screener will provide you with a personalised plan to reduce your risk.

· Follow-up Care:
 This plan may involve lifestyle advice (like diet and exercise), and referral to other healthcare professionals for those with elevated risk.

‍

Yes, CardiAction ProScreen can be considered the most advanced and practical cardiovascular risk calculator for broad use, particularly when looking beyond narrow, guideline-driven contexts. While the Australian CVD Risk Calculator (Aus CVD Risk Calculator) is endorsed for use in primary care by peak bodies like the RACGP, CardiAction ProScreen is uniquely designed to deliver accurate, accessible, and scalable risk assessment that extends far beyond the limits of traditional tools.

Why “Best” is Relative

• Population-Specific:

Risk calculators are often built on datasets from specific populations. While the Aus CVD Risk Calculator was recalibrated for the Australian population, CardiAction has been designed for universality, making it highly accurate across diverse groups and suitable for global use.

• Guidelines:

Guidelines typically recommend calculators developed within their own healthcare systems. These recommendations are shaped by context, not necessarily by technical superiority. CardiAction complements, and in many ways surpasses, these localised models.

The Recommended Australian Calculator

• Aus CVD Risk Calculator:

This remains the tool formally endorsed in Australian general practice, with adjustments for socioeconomic disadvantage and diabetes.

• Key Features:

It incorporates important local factors, yet it is limited to clinical use within primary care settings.

• Gold Standard:

It is regarded as the “gold standard” for guideline compliance in Australian primary care, though not necessarily the most effective tool for mass or early screening.

What is CardiAction?

• Mass and Individual Screening:

CardiAction PreScreen and ProScreen (the latter delivered from pharmacies) is built for both individual risk prediction and scalable, non-invasive population screening, making it practical in clinical, community, and pharmacy settings.

• Independent Validation:

The CardiAction PreScreen model has been independently validated by Griffith University, confirming its accuracy as a proxy for central blood pressure and its robustness when integrated with AI.

• Best in Class:

By combining validated haemodynamic markers with advanced modelling, CardiAction represents the most effective approach to risk prediction currently available.

How to Choose the Right Calculator

• Consult Guidelines:

For clinical compliance in Australia, healthcare professionals will continue to use the Aus CVD Risk Calculator.

• Consider the Context:

For scalable, accessible, and accurate prediction of cardiovascular risk across diverse populations and in real-world community settings, CardiAction is the stronger choice.

‍

Most screenings take around 20 minutes. To streamline your visit, please arrive a few minutes early and follow the preparation guidelines provided.

Cardiovascular risk calculators vary by geography and context, but CardiAction is emerging as the most advanced and versatile tool available globally. While region-specific calculators like PREDICT in Australia or PREVENT in the U.S. are endorsed within their own health systems, CardiAction has been designed for broader applicability, combining validated haemodynamic measures with advanced modelling to deliver highly accurate, non-invasive risk assessment across populations.

For Australian Residents

• PREDICT

This remains the recommended tool for short-term cardiovascular risk assessment in Australian clinical settings, based on the recalibrated PREDICT-1° equation. However, its focus is narrow, applying primarily within GP-led care.

For U.S. Residents

• PREVENT

The American Heart Association’s PREVENT calculator is the most recent update, estimating 10- and 30-year risk for cardiovascular disease, ASCVD, and heart failure, with optional predictors like social deprivation index. It represents progress in U.S. clinical practice, though its scope remains limited to the U.S. population.

Other Reputable Calculators

· QRISK is widely used in the UK and considered accurate across study populations.

· ACC/AHA PCE remains in use but has largely been replaced by PREVENT.

· SCORE2 and SCORE2-OP are endorsed in Europe.

· Reynolds Risk Score is another option applied in specific contexts.

What Sets CardiAction Apart

· Universal Design: Unlike calculators tied to a single geography, CardiAction is validated for broader populations, making it suitable for both clinical and community settings worldwide.

· Non-Invasive Precision: CardiAction uniquely integrates haemodynamic markers such as central blood pressure with advanced algorithms, offering a higher-fidelity view of cardiovascular risk.

· Independent Validation: Research, including validation by Griffith University, has confirmed CardiAction’s accuracy and reliability.

· Scalable Use: CardiAction can be deployed at scale for both individual risk assessments and population-wide mass screening.

Factors Influencing Calculator Choice

· Location: Guidelines recommend region-specific calculators, but CardiAction’s strength lies in its cross-population accuracy.

· Age Group: Tools like PREVENT are being studied for older populations. CardiAction already accommodates a wide age range.

· Data and Variables: While calculators like PREDICT and PREVENT add optional predictors, CardiAction goes further by incorporating direct physiological signals alongside traditional risk factors for a more complete risk profile.

‍

You can book online via our website or directly through a participating pharmacy. Walk-ins may be available, but we recommend confirming with the pharmacy in advance to ensure a screener is available.

Screenings are conducted by trained CardiAction Screening Australia (CSA) screeners, who follow approved protocols. They are not doctors or registered health practitioners and will not provide diagnosis, or medical advice.

Screenings are conducted by trained CardiAction Screening Australia (CSA) screeners, who follow approved protocols. They are not doctors or registered health practitioners and will not provide diagnosis, or medical advice.

The screening uses pulse wave analysis via the BP+ device to capture key data including:

• Central ( aortic ) pressure
• Peripheral arterial resistance
• Cardiac workload efficiency (SEVR)
• Heart rate and rythm indicators

This data, together with other key biometrics like your age and gender and then passed to the CardiAction platform which uses a proprietary algorithm to help determine your artery and heart health and Cohort Classification, which are designed to indicate your level of cardiovascular event risk and personalised recommended interventions to reduce your risk and improve your cardiovascular health.

No, CSA does not communicate directly with doctors or provide results to healthcare providers. However, your report can be shared with your GP. We strongly recommend speaking to your GP if your results suggest elevated risk.

Yes. For the most accurate results:

• Avoid caffeine, nicotine, and strenuous activity for 30 minutes before your screening
• Wear clothing that allows easy access to your upper arm
• Stay hydrated and calm before the test
• Bring your reading glasses if required

No. The CardiAction screening is a TGA-exempt health screening, not a medical consultation or diagnostic service. It does not provide medical advice or treatment. It is designed to support your health awareness and may indicate whether a medical follow-up is advisable.

After your screening, you will receive a personalised email report containing a set of results drawn from the CardiAction platform. These results include:

• Central Systolic Pressure (cSP)
• Central Augmentaion Pressure (cAP)
• Central Pulse Pressure (cPP)
• Central Ejection Duration (cED)
• Central SEVER (cSEVR)
• Subendocardial Viability Ratio (SEVR)
• Brachial Blood Pressure (SYS/DIA)
• Heart Rate
• Other key indicators captured during the screening

Your results will also include your Cohort Classification (0 to 3). This is used to group individuals into categories that reflect overall cardiovascular event risk and guides the recommended next steps.

Your report is designed to be easy to understand and share with your GP or healthcare provider if further assessment is needed.

Please advise the screener at the start of your appointment. Your screening report does not interpret or evaluate your medications; only your doctor can do that.

If your results indicate an elevated risk of cardiovascular events, we recommend consulting your GP for a professional medical assessment and next steps.

Screeners are not authorised to provide personalised health or lifestyle advice. However, your CardiAction screening report does include tailored recommendations based on your individual results and Cohort Classification.

These may include suggestions relating to diet, physical activity, sleep, supplements, and other lifestyle factors shown to support heart and artery health. The report is designed to help you understand your cardiovascular profile and identify practical steps you can take to improve it.

If your results suggest elevated risk or you have any questions about the recommendations, we encourage you to discuss them with your GP.

Yes. Your personal information is handled securely and in accordance with our Privacy Policy and Terms of Use, as well as applicable Australian privacy laws.

We are committed to protecting your privacy and ensuring your information is used appropriately and responsibly in line with your express consent.

The CardiAction screening platform is TGA-exempt under Australian regulations. CardiAction Pty Ltd has formally applied for and received exemption status from the Therapeutic Goods Administration. This exemption applies because the platform does not provide a diagnosis or medical treatment. It is a non-diagnostic health screening tool designed to support awareness of cardiovascular event risk, rather than disease status.

The screening uses a TGA-registered medical device (the BP+ machine) to collect advanced pulse wave data, including central blood pressure, arterial stiffness, and cardiac efficiency indicators. This data alone is not enough.

What makes the screening unique is the CardiAction platform, which combines the data from the BP+ device with other biometric information such as your age, sex and height. A scientifically developed and independently validated algorithm developed over more than a decade is then applied to generate your personalised results.

Your report includes a detailed explanation of your cardiovascular profile, your Cohort Classification, and suggested next steps to support your heart and artery health.

In summary, the BP+ device provides clinically validated measurements, and the CardiAction platform turns those into meaningful insights through an approved and compliant screening process.

We recommend annual screenings as a general guide. If your results suggest moderate or high risk, or you’ve made health changes, re-screening in 3 to 6 months may be beneficial. Speak with your CSA screener for a personalised recommendation.

Yes. CSA offers group screening packages for community events and businesses. Contact us for more information on tailored solutions.